This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rolan, P. E.
Right arrow Articles by Posner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rolan, P. E.
Right arrow Articles by Posner, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 06 1997, 1319-1321, Vol 41, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Disposition of atovaquone in humans

PE Rolan, AJ Mercer, E Tate, I Benjamin and J Posner
Department of Clinical Pharmacology, Wellcome Research Laboratories, Beckenham, Kent, United Kingdom.

Atovaquone is an antiprotozoal compound with good in vitro stability against metabolic inactivation. Previous human studies which did not involve radiolabelling had not accounted for a substantial proportion of the dose. The possible metabolism of atovaquone in men was examined in a radiolabelling study involving four healthy male volunteers. Radioactivity was eliminated almost exclusively via the feces. All radioactivity in plasma, urine, and feces was accounted for by atovaquone, with no evidence of metabolites. Radiolabelled atovaquone was administered to a patient with an indwelling biliary tube after surgery. Biliary radioactivity was approximately 10- to 40-fold higher than that in plasma and was accounted for by atovaquone. Atovaquone is not significantly metabolized in humans but is excreted into bile against a high concentration gradient.


This article has been cited by other articles:

  • Baggish, A. L., Hill, D. R. (2002). Antiparasitic Agent Atovaquone. Antimicrob. Agents Chemother. 46: 1163-1173 [Full Text]  
  • Gupta, S., Thapar, M. M., Wernsdorfer, W. H., Bjorkman, A. (2002). In Vitro Interactions of Artemisinin with Atovaquone, Quinine, and Mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother. 46: 1510-1515 [Abstract] [Full Text]